Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 145,587 | 166,460 | 128,568 | 158,559 | 119,849 |
| Cost of Goods | 67,560 | 88,637 | 66,015 | 81,157 | 57,195 |
| Gross Profit | 78,027 | 77,823 | 62,553 | 77,402 | 62,654 |
| Operating Expenses | 49,128 | 48,290 | 44,102 | 42,031 | 37,466 |
| Operating Income | 29,459 | 30,170 | 18,466 | 35,528 | 25,383 |
| Interest Expense | 145 | 423 | 39 | 77 | 53 |
| Other Income | 358 | 187 | 207 | -1,749 | 337 |
| Pre-tax Income | 29,672 | 29,934 | 18,634 | 33,702 | 25,667 |
| Income Tax | 9,635 | 11,262 | 6,269 | 11,772 | 8,486 |
| Net Income Continuous | 20,037 | 18,672 | 12,365 | 21,930 | 17,181 |
| Minority Interests | N/A | N/A | N/A | N/A | -39 |
| Net Income | $20,037 | $18,672 | $12,365 | $21,872 | $17,220 |
| EPS Basic Total Ops | 0.30 | 0.29 | 0.19 | 0.33 | 0.27 |
| EPS Basic Continuous Ops | 0.30 | 0.29 | 0.19 | 0.34 | 0.27 |
| EPS Diluted Total Ops | 0.29 | 0.27 | 0.18 | 0.31 | 0.26 |
| EPS Diluted Continuous Ops | 0.29 | 0.27 | 0.18 | 0.32 | 0.26 |
| EBITDA(a) | $31,822 | $49,464 | $22,857 | $39,952 | $29,403 |